Status:

COMPLETED

A Study to Test Performance of Needle Placements for Neuraxial Procedures Using Tactile Imaging vs Control

Lead Sponsor:

IntuiTap Medical, Inc

Collaborating Sponsors:

ICON plc

Conditions:

Central Nervous System Infections

Pseudotumor Cerebri

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study will compare the VerTouch device to the conventional palpation technique for performing diagnostic and therapeutic neuraxial procedures.

Detailed Description

Neuraxial procedures, in which a needle is inserted into the spinal canal through a gap in the vertebrae, are performed at a rate of nearly 13 million per year in the US, across a myriad of diagnostic...

Eligibility Criteria

Inclusion

  • Males and females aged 18 years and above, inclusive
  • Subjects scheduled for one of the following procedures:
  • Diagnostic LP (collection of CSF and/or measurement of ICP to diagnose hemorrhaging or neurological infections)
  • Therapeutic LP (intrathecal injection of therapeutic agents; drainage of CSF to treat pseudotumor cerebri)
  • Planned orthopedic or obstetric procedure, such as labor/induction, cesarean section, hysterectomy, or total hip/knee replacement, with neuraxial anesthesia (injection of anesthetic into spinal and/or epidural space to reduce pain during procedure)
  • Epidural blood patch (use of autologous blood to close holes in the dura mater and relieve PDPH)
  • Subjects having a BMI ≤42kg/m2

Exclusion

  • Patient does not provide informed consent
  • Skin or soft tissue infection near the puncture site
  • Allergy to local anesthetic
  • Uncorrected coagulopathy
  • Acute spinal cord trauma
  • History of lumbar spinal surgery
  • Prior known failed neuraxial anesthesia
  • Diagnosed scoliosis, thoracic kyphosis, lumbar lordosis, scleroderma, or ankylosing spondylitis, or lumbar spinal stenosis
  • Incarcerated subjects

Key Trial Info

Start Date :

April 4 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 24 2021

Estimated Enrollment :

95 Patients enrolled

Trial Details

Trial ID

NCT04796935

Start Date

April 4 2021

End Date

November 24 2021

Last Update

June 11 2024

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Rhode Island Hospital

Providence, Rhode Island, United States, 02903

2

Medical University of South Carolina

Charleston, South Carolina, United States, 29425

3

University of Texas Health Science Center

Houston, Texas, United States, 77030